Home Newsletters Cancer Stem Cell News Glioblastoma Stem Cells Reprogram Chromatin In Vivo to Generate Selective Therapeutic Dependencies...

Glioblastoma Stem Cells Reprogram Chromatin In Vivo to Generate Selective Therapeutic Dependencies on DPY30 and Phosphodiesterases

0
Scientists identified DPY30, a regulator of histone H3 lysine 4 trimethylation, as a driver of glioblastoma growth in vivo but not in vitro.
[Science Translational Medicine]
6445212 AAAAAAAA items 1 apa 0 default asc 1 170572 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version